Changes in Proteinase-Activated Receptor 2 Expression in the Human Tooth Pulp in Relation to Caries and Pain

Aims: To investigate the presence of proteinase-activated receptor 2 (PAR2) in the human tooth pulp and to determine whether there are any changes in receptor expression with caries and pain. Methods: Forty-four mandibular first permanent molars were collected from children (n = 36, mean age 9.96 years ± 2.11) requiring dental extractions under general anesthesia. Teeth were categorized as either intact (n = 22) or carious (n = 22). Carious teeth were further subdivided into asymptomatic (n = 10) and painful (n = 12). The coronal pulp was removed and processed for indirect immunofluorescence by using antibodies raised against PAR2 and double labeled with either a neuronal marker (protein gene product 9.5) or both a smooth muscle cell (aSMA) and endothelial (UEIL) marker, in order to examine PAR2 presence in both neuronal and vascular tissue. In addition, hemotoxylin and eosin staining was performed to identify pulpal fibroblasts. Results: PAR2 expression was found to be present in pulpal nerve fibers, vascular tissue, and pulpal fibroblasts. PAR2 neuronal expression was not affected by the presence of caries (P > .05) but was significantly less in carious painful teeth than in carious asymptomatic teeth (P < .05). No changes in vascular PAR2 expression were found (P > .05); however, the number of PAR2-labeled fibroblast-like cells per mm2 was significantly greater in carious teeth (P < .05). Conclusion: These findings indicate that PAR2 receptors and changes in their level of expression may have relevance and clinical importance in nociception.

caries; human tooth pulp; immunohistochemistry; pain; proteinase-activated receptor 2

1. Steinhoff M, Vergnolle N, Young SG, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000;6:151–158.

2. Vergnolle N, Bunnett NW, Sharkey KA, et al. Proteinase-activated receptor 2 and hyperalgesia: A novel pain pathway. Nat Med 2001;7:821–826.

3. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033–1079.

4. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987;84:2975–2979.

5. Amadesi S, Nie J, Vergnolle N, et al. Proteinase-activated receptor 2 sensitises the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004;24:4300–4312.

6. Dai Y, Moriyama T, Higashi T, et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004;24:4293–4299.

7. Dattilio A, Vizzard MA. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalisation with capsaicin (VR1) in bladder nerve fibres. J Urol 2005;173:635–639.

8. Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 2006;125:114–124.

9. Morgan CR, Rodd HD, Clayton N, Davis JB, Boissonade FM. Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain. J Orofac Pain 2005;19: 248–260.

10. Tancharoen S, Sarker KP, Imamura T, et al. Neuropeptide release from dental pulp cells by RgpB via proteinase-activated receptor-2 signalling. J Immunol 2005;174: 5796–5804.

11. Sessle BJ. Acute and chronic craniofacial pain: Brainstem mechanisms of nociceptive transmission and neuroplasticity and their clinical correlates. Crit Rev Oral Biol Med 2000;11:57–91.

12. Anderson DJ, Hannam AG, Mathews B. Sensory mechanisms in mammalian teeth and their supporting structures. Physiol Rev 1970;50:171–195.

13. Byers MR, Narhi MV. Dental injury models: Experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions. Crit Rev Oral Biol Med 1999;10:4–39.

14. Matthews B. The mechanisms of pain from dentine and pulp. Br Dent J 1976;140:57–60.

15. Matthews B. Peripheral and central aspects of trigeminal nociceptive systems. Philos Trans R Soc Lond B Biol Sci 1985;308:313–324.

16. Chatrian GE, Canfield RC, Knauss TA, Eegt EL. Cerebral responses to electrical tooth pulp stimulation in man. An objective correlate of acute experimental pain. Neurology 1975;25:745–757.

17. Närhi M, Yamamoto H, Ngassapa D, Hirvonen T. The neurophysiological basis and the role of inflammatory reactions in dentine hypersensitivity. Arch Oral Biol 1994;39(suppl):23S–30S.

18. Närhi M, Jyväsjärvi E, Virtanen A, Huopaniemi T, Ngassapa D, Hirvonen T. Role of intradental A- and C- type nerve fibres in dental pain mechanisms. Proc Finn Dent Soc 1992;88:507–516.

19. Cobourne M, Williams A, McMullan R. A Guideline for First Permanent Molar Extraction in Children. Royal College of Surgeons website, 2004. http://www.rcseng. ac.uk/fds/clinical_guidelines. Accessed June 29, 2007.

20. Rodd HD, Boissonade FM. Immunocytochemical investigation of neurovascular relationships in human tooth pulp. J Anat 2003;202:195–203.

21. Rodd HD, Boissonade FM. Comparative immunohistochemical analysis of the peptidergic innervation of human primary and permanent tooth pulp. Arch Oral Biol 2002;47:375–385.

22. Ekblom A, Hansson P. A thin-section and freeze fracture study of the pulp vessels in feline and human teeth. Arch Oral Biol 1984;29:413–424.

23. Okamura K, Kobayashi I, Matsuo K, et al. Ultrastructure of the neuromuscular junction of vasomotor nerves in the microvasculature of human dental pulp. Arch Oral Biol 1994;39:171–176.

24. Matsumoto Y, Kato S, Miura M, Yanagisawa S, Shimizu

M. Fine structure and distribution of lymphatic vessels in the human dental pup: A study using an enzyme-histochemical method. Cell Tissue Res 1997;288:79–88.

25. D’Andrea MR, Derian CK, Leturcq D, et al. Characterisation of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 1998;46:157–164.

26. Hollenberg MD, Saifeddine M, al-Ani B. Proteinase-acti- vated receptor-2 in rat aorta: Structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 1998;49:229–233.

27. Dai Y, Wang S, Tominaga M, et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 2007;117:1979–1987.

28. Déry O, Thoma MS, Wong H, Grady EF, Bunnett NW. Trafficking of proteinase-activated receptor-2 and �-arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 1999;274:18524–18535.

29. Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG, Bunnett NW. Mechanisms of desensitisation and resensitisation of proteinase-activated receptor-2. J Biol Chem 1996;271:22003–22016.

30. D’Andrea MR, Saban MR, Nguyen NB, Andrade-Gordon P, Saban R. Expression of protease-activated receptor-1,- 2,-3, and -4 in control and experimentally inflamed mouse bladder. Am J Path 2003;162:907–923.

31. Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007;117:636–647.

32. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994;91:9208–9212.

33. Nystedt S, Emilsson K, Larsson AK, Strombeck B, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995;232:84–89.

34. Cicala C, Pinto A, Bucci M, et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 1999;99:2590–2597.

35. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PA4 agonists. Circ Res 2001;89:92–98.

36. Tønder KJ. Vascular reactions in the dental pulp during inflammation. Acta Odontol Scand 1983;41:247–256.

37. Akers IA, Parsons M, Hill MR, et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 2000;278:L193–L201.

38. Gruber BL, Marchese MJ, Santiago-Schwarz F, Martin CA, Zhang J, Kew RR. Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. J Invest Dermatol 2004;123:832–839.

39. Ramachandran R, Morice AH, Compton SJ. Proteinase- activated receptor 2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts. Am J Respir Cell Mol Biol 2006;35:133–141.

40. D’Andrea MR, Derian CK, Santulli RJ, Andrade-Gordon

P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal. Benign and malignant human tissues. Am J Path 2001;158:2031–2041.

41. Fitzgerald M, Chiego DJ Jr, Heys DR. Autoradiographic analysis of odontoblast replacement following pulp exposure in primate teeth. Arch Oral Biol 1990;35:707–715.

42. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997;99:1313–1321.

43. Gruber BL. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 2003;5:147–153.

44. Wislocki GB, Sognnaes RF. Histochemical reactions of normal teeth. Am J Anat 1950;87:239–276.

45. Dockrill TE. Tissue mast cells in the oral cavity. Aust Dent J 1961;6:210–214.

46. Photo P, Antila R. Assay of histamine in dental pulps. Acta Odontol Scand 1970;28:691–699.

47. Zachrisson BU. Mast cells in human dental pulp. Arch Oral Biol 1971;16:555–556.

48. Skogedal O. Intracellular complex carbohydrates in the normal and inflamed dental pulp. Scand J Dent Res 1973;81:558–562.

49. Miller GS, Sternberg RN, Piliero SJ, Rosenberg PA. Histologic identification of mast cells in human dental pulp. Oral Surg Oral Med Oral Pathol 1978;46:559–566.

50. Farnoush A. Mast cells in human dental pulp. J Endod 1984;10:250–252.

51. Walsh LJ, Davis MF, Savage NW. Relationship between mast cell degranulation and inflammation in the oral cavity. J Oral Pathol Med 1995;24:266–272.

52. Rodd HD, Boissonade FM. Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent 2006;16:2–9.

53. Choi KL, Claman HN. Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells. Immunol Res 1987;6:145–152.

54. Langeland K, Rodrigues H, Dowden W. Periodontal disease, bacteria, and pulpal histopathology. Oral Surg Oral Med Oral Pathol 1974;37:257–270.

55. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003;74:111–118.